补充烟酰胺核糖减轻脓毒症T细胞耗竭并改善生存
该研究在经典脓毒症动物模型中观察到脓毒症时T细胞NAD+及其下游分子SIRT1水平下降。盲肠结扎穿孔后立即补充NAD+前体烟酰胺核糖,可显著升高NAD+与SIRT1水平,减轻脾脏单核细胞和T淋巴细胞耗竭,增加CD3+CD4+与CD3+CD8+T细胞水平,使Th1与Th2细胞均扩增但Th1/Th2平衡部分恢复。烟酰胺核糖还抑制调节性T细胞扩增及CD4+T细胞程序性死亡受体1表达,并降低脓毒症小鼠的细菌负荷、肺心肝肾脏器损伤和死亡率。作者认为烟酰胺核糖对脓毒症及T细胞耗竭的有益作用与NAD+/SIRT1通路相关。
要点
- 在经典脓毒症动物模型中,脓毒症时T细胞NAD+及其下游分子SIRT1水平下降。
- 盲肠结扎穿孔后立即补充烟酰胺核糖(NAD+前体)可显著升高T细胞NAD+与SIRT1水平。
- 烟酰胺核糖减轻脾脏单核细胞与T淋巴细胞耗竭,增加CD3+CD4+与CD3+CD8+T细胞水平,使Th1与Th2细胞均扩增而Th1/Th2平衡部分恢复。
- 烟酰胺核糖抑制脓毒症时调节性T细胞扩增及CD4+T细胞程序性死亡受体1表达。
- 烟酰胺核糖降低脓毒症小鼠细菌负荷、肺心肝肾脏器损伤与死亡率。
适用人群与场景
- 经典脓毒症动物模型(小鼠),于盲肠结扎穿孔后立即给予烟酰胺核糖。
处置流程与药物剂量
- 烟酰胺核糖为NAD+前体,于盲肠结扎穿孔后立即补充;原文未给出具体剂量、给药途径与疗程。
研究设计与关键结果
- 研究类型为经典脓毒症动物模型实验;脓毒症时T细胞NAD+与SIRT1水平下降,补充烟酰胺核糖后显著升高。
- 烟酰胺核糖减轻脾脏单核细胞和T淋巴细胞耗竭,增加CD3+CD4+与CD3+CD8+T细胞水平;Th1与Th2细胞均扩增,Th1/Th2平衡部分恢复。
- 烟酰胺核糖抑制调节性T细胞扩增及CD4+T细胞程序性死亡受体1表达。
- 烟酰胺核糖降低脓毒症小鼠细菌负荷、肺心肝肾脏器损伤与死亡率。
证据类型、等级与局限
- 证据类型:经典脓毒症动物模型实验。
- 作者结论:烟酰胺核糖对脓毒症及T细胞耗竭的有益作用与NAD+/SIRT1通路相关。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文为动物实验,未据此给出临床推荐;作者认为烟酰胺核糖对脓毒症及T细胞耗竭的有益作用与NAD+/SIRT1通路相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
T cell exhaustion is the main cause of sepsis-induced immunosuppression and is associated with the poor prognosis. Nicotinamide adenine dinucleotide (NAD + ) is well known for its anti-aging effect, but its role in sepsis-induced T cell exhaustion remains to be elucidated. In the present study, using a classic septic animal model, we found that the levels of NAD + and its downstream molecule, which is sirtuins 1 (SIRT1), in T cells in sepsis were decreased. Supplementation with nicotinamide ribose (NR), the precursor of NAD + , right after cecal ligation and puncture significantly increased the levels of NAD + and SIRT1. Supplementation with NR alleviated the depletion of mononuclear cells and T lymphocytes in spleen in sepsis and increased the levels of CD3 + CD4 + and CD3 + CD8 + T cells. Interestingly, both Th1 and Th2 cells were expanded after NR treatment, but the balance of Th1/Th2 was partly restored. Nicotinamide ribose also inhibited the regulatory T cells expansion and programmed cell death 1 expression in CD4 + T cells in sepsis. In addition, the bacteria load, organ damage (lung, heart, liver, and kidney), and the mortality of septic mice were reduced after NR supplementation. In summary, these results demonstrate the beneficial effect of NR on sepsis and T cell exhaustion, which is associated with NAD + /SIRT1 pathway.
参考来源
- Zhao GJ, Yang XY, Zhang C, et al. SUPPLEMENTATION WITH NICOTINAMIDE RIBOSIDE ATTENUATES T CELL EXHAUSTION AND IMPROVES SURVIVAL IN SEPSIS. Shock. 2023. PMID: 37314209. doi:10.1097/SHK.0000000000002153
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。